{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:52:33Z","timestamp":1793393553915,"version":"4.5.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Alcon Research Investigator Initiated Trial grant","award":["IIT # 78522193"],"award-info":[{"award-number":["IIT # 78522193"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec021\">\n<jats:title>Background<\/jats:title>\n<jats:p>Dry eye disease (DED) is a complex ocular disorder with a significant prevalence worldwide, especially in the Asian population. This study aimed to investigate changes in dry eye symptoms and signs following regular use of a new nanoemulsion eye drop, Systane COMPLETE Multi-Dose Preservative-Free (MDPF), in patients with mild to moderate DED in the Asian population.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec022\">\n<jats:title>Methods and design<\/jats:title>\n<jats:p>This is a prospective cohort study (ClinicalTrials.gov identifier: NCT06188260) that aims to recruit approximately 40 patients from the Asian population suffering from mild to moderate DED. Mild to moderate DED is defined according to the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II diagnostic criteria, including an Ocular Surface Disease Index (OSDI) score between 13\u201332, and with at least one of the following positive signs: corneal staining, Non-Invasive Tear Breakup Time (NITBUT), or osmolarity. The proposed follow-up period is 3 months. Patients undergo three assessments: baseline before using the eye drops, and follow-up visits after 2 weeks and 3 months regular use of the eye drops (four times daily). The primary outcome is the change in the OSDI score at 2 weeks.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec023\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>The results examine the dry eye symptoms before and after using the new nanoemulsion eye drop, Systane COMPLETE MDPF, in a cohort of mild to moderate DED sufferers. The findings may provide new treatment options for dry eye sufferers with significant clinical implications.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0323523","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T17:38:26Z","timestamp":1746812306000},"page":"e0323523","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of a new nanoemulsion artificial tear in dry eye disease management: Study protocol for a prospective cohort study"],"prefix":"10.1371","volume":"20","author":[{"given":"Xulin","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6282-8143","authenticated-orcid":true,"given":"Biyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0201-6842","authenticated-orcid":true,"given":"Jimmy S.H.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"2","key":"pone.0323523.ref001","doi-asserted-by":"crossref","first-page":"020503","DOI":"10.7189\/jogh.08.020503","article-title":"Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis","volume":"8","author":"P Song","year":"2018","journal-title":"J Glob Health"},{"key":"pone.0323523.ref002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajo.2019.01.026","article-title":"Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System","volume":"202","author":"R Dana","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"pone.0323523.ref003","first-page":"276","volume":"15","author":"JP Craig","year":"2017","journal-title":"TFOS DEWS II definition and classification report"},{"issue":"3","key":"pone.0323523.ref004","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"F Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"7","key":"pone.0323523.ref005","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2015.02.037","article-title":"Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye","volume":"122","author":"F Amparo","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"pone.0323523.ref006","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clae.2020.02.018","article-title":"Agreement and repeatability of four different devices to measure non-invasive tear breakup time (NIBUT)","volume":"43","author":"S Bandlitz","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"pone.0323523.ref007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clae.2017.09.012","article-title":"The potential influence of Schirmer strip variables on dry eye disease characterisation, and on tear collection and analysis","volume":"41","author":"N Garc\u00eda-Porta","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"pone.0323523.ref008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clae.2010.01.007","article-title":"Evaluation of the effects on conjunctival tissues of Optive eyedrops over one month usage","volume":"33","author":"M Guillon","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"pone.0323523.ref009","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"JS Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"pone.0323523.ref010","first-page":"581","article-title":"Diagnosis of dry eye disease and emerging technologies","volume":"8","author":"MS-B Zeev","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"pone.0323523.ref011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"L Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"pone.0323523.ref012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcjo.2016.01.005","article-title":"Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease","volume":"51","author":"PK Gupta","year":"2016","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"pone.0323523.ref013","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1475-1313.2009.00683.x","article-title":"Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review","volume":"29","author":"MJ Doughty","year":"2009","journal-title":"Ophthalmic Physiol Opt"},{"key":"pone.0323523.ref014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/OPTO.S398496","article-title":"Quality of Life in Digital Device Users Who are Treated with Systane Hydration PF","volume":"15","author":"AD Pucker","year":"2023","journal-title":"Clin Optom (Auckl)"},{"issue":"5","key":"pone.0323523.ref015","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms23052434","article-title":"Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease","volume":"23","author":"M Labetoulle","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0323523.ref016","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.2147\/OPTH.S377960","article-title":"Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease","volume":"16","author":"S Srinivasan","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"pone.0323523.ref017","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/jop.2018.0031","article-title":"Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium","volume":"35","author":"R Rangarajan","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"pone.0323523.ref018","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/OPTH.S263362","article-title":"Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial","volume":"14","author":"S Silverstein","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"pone.0323523.ref019","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41433-018-0019-1","article-title":"The effect of the timing of the cessation of contact lens use on the results of biometry","volume":"32","author":"C Goudie","year":"2018","journal-title":"Eye (Lond)"},{"issue":"1","key":"pone.0323523.ref020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/ICL.0000000000000351","article-title":"Meibomian Gland Dysfunction and Contact Lens Discomfort","volume":"43","author":"R Arita","year":"2017","journal-title":"Eye Contact Lens"},{"key":"pone.0323523.ref021","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jtos.2020.12.006","article-title":"Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial","volume":"20","author":"JP Craig","year":"2021","journal-title":"Ocul Surf"},{"issue":"5","key":"pone.0323523.ref022","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1177\/1120672120969035","article-title":"Ocular surface analysis: A comparison between the LipiView\u00ae II and IDRA\u00ae","volume":"31","author":"JM Lee","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"pone.0323523.ref023","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00417-020-05044-5","article-title":"Characteristics of dry eye patients with thick tear film lipid layers evaluated by a LipiView II interferometer","volume":"259","author":"Y Lee","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"pone.0323523.ref024","first-page":"1496","article-title":"Lipid layer thickness and tear meniscus height measurements for the differential diagnosis of evaporative dry eye subtypes","volume":"11","author":"X Sang","year":"2018","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"pone.0323523.ref025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1367-0484(01)00005-4","article-title":"The tear (lacrimal) meniscus height in human eyes: a useful clinical measure or an unusable variable sign?","volume":"25","author":"MJ Doughty","year":"2002","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"pone.0323523.ref026","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clae.2010.01.003","article-title":"Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness","volume":"33","author":"U Benelli","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"issue":"202","key":"pone.0323523.ref027","article-title":"Advancing tear fluid analysis using a standardized protocol for proteomics research (Video).","author":"JS-H Tse","year":"2023","journal-title":"JoVE"},{"issue":"5","key":"pone.0323523.ref028","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ajo.2014.02.012","article-title":"Reliability of 4 clinical grading systems for corneal staining","volume":"157","author":"Y Sook Chun","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"pone.0323523.ref029","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/OPX.0000000000000919","article-title":"Lid Wiper Epitheliopathy in Soft Contact Lens Wearers","volume":"93","author":"M-M Schulze","year":"2016","journal-title":"Optom Vis Sci"},{"issue":"1","key":"pone.0323523.ref030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2017.10.005","article-title":"Randomized double-masked trial of eyelid cleansing treatments for blepharitis","volume":"16","author":"J Sung","year":"2018","journal-title":"Ocul Surf"},{"issue":"2","key":"pone.0323523.ref031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICO.0000000000002997","article-title":"Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study","volume":"42","author":"G Giannaccare","year":"2022","journal-title":"Cornea"},{"issue":"11","key":"pone.0323523.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.04.037","article-title":"Proposed diagnostic criteria for obstructive meibomian gland dysfunction","volume":"116","author":"R Arita","year":"2009","journal-title":"Ophthalmology"},{"issue":"11","key":"pone.0323523.ref033","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.18240\/ijo.2019.11.07","article-title":"Comparison of anti-inflammatory effects of intense pulsed light with tobramycin\/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction","volume":"12","author":"Y-F Gao","year":"2019","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"pone.0323523.ref034","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12886-018-0671-z","article-title":"Coping with dry eyes: a qualitative approach","volume":"18","author":"S Yeo","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"pone.0323523.ref035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.7.5.18","article-title":"Effect of Ultrasonic Moisture Glasses on Dry Eye Signs and Symptoms","volume":"7","author":"S Onomura","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"pone.0323523.ref036","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cxo.12541","article-title":"Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction","volume":"101","author":"JM Albietz","year":"2018","journal-title":"Clin Exp Optom"},{"issue":"4","key":"pone.0323523.ref037","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","article-title":"A new system, the LipiFlow, for the treatment of meibomian gland dysfunction","volume":"31","author":"SS Lane","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"pone.0323523.ref038","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"K Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"pone.0323523.ref039","article-title":"The treatment of dry eye","author":"M Calonge","year":"2001","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"pone.0323523.ref040","doi-asserted-by":"crossref","first-page":"101399","DOI":"10.1016\/j.clae.2020.12.004","article-title":"Application of systane complete for the treatment of contact lens discomfort","volume":"44","author":"AD Pucker","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"pone.0323523.ref041","first-page":"55","article-title":"An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population. Current medical research and opinion","volume":"28","author":"I Hartstein","year":"2004","journal-title":"Curr Eye Res"},{"key":"pone.0323523.ref042","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2147\/OPTH.S164888","article-title":"Efficacy of polyethylene glycol-propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease","volume":"12","author":"A Aguilar","year":"2018","journal-title":"Clin Ophthalmol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T17:38:34Z","timestamp":1746812314000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323523"}},"subtitle":[],"editor":[{"given":"Liat","family":"Gantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0323523","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}